Maria Sánchez-Purrà

Maria Sánchez-Purrà

Auto-generated profile, based on publicly available information

Maria Sánchez-Purrà

Department of Engineering, University of Massachusetts, Boston, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2017 in Molecular Systems Design & Engineering
Verified
Journal Article
Closed access
PDF file
MSMaria Sánchez-Purrà
Maria Sánchez-Purrà
BRBiel Roig-Solvas
Biel Roig-Solvas
AVAlice Versiani
Alice Versiani
CRCristina Rodriguez-Quijada
Cristina Rodriguez-Quijada
HPHelena de Puig
Helena de Puig
Kimberly Hamad-SchifferliKimberly Hamad-Schifferli
Kimberly Hamad-Schifferli
Surface enhanced Raman spectroscopy (SERS) can be used to enhance the sensitivity of lateral flow immunoassays.

28 May 2019 in Nanoscale
Verified
Journal Article
Closed access
PDF file
LRLorenzo Russo
Lorenzo Russo
MSMaria Sánchez-Purrà
Maria Sánchez-Purrà
CRCristina Rodriguez-Quijada
Cristina Rodriguez-Quijada
BLBrianna M. Leonardo
Brianna M. Leonardo
VPVictor Puntes
Victor Puntes
Kimberly Hamad-SchifferliKimberly Hamad-Schifferli
Kimberly Hamad-Schifferli
Myxovirus protein A (MxA) is a biomarker that can be used to distinguish between viral and bacterial infections. While MxA lateral flow assays (LFAs) have been successfully used for viral vs. bacterial differential diagnosis for children, the clinically relevant level of MxA for adults has been reported to be 100 times lower, which is too low for traditional LFAs. We present results applying the use of surface enhanced Raman spectroscopy (SERS) to detect MxA. AuAg nanoshells (AuAg NSs) were used to enhance the Raman signal of mercaptobenzoic acid (4-MBA), enabling readout by SERS. The AuAg NSs were conjugated to antibodies for the biomarker of interest, resulting in a “nanotag”, that could be used in a dipstick immunoassay for detection. We first optimized the nanotag parameters using anti-human IgG/human IgG as a model antibody/antigen system, and then demonstrated detection of MxA using anti-MxA antibodies. We show that SERS readout of immunoassays for MxA can quantify MxA levels at clinically relevant levels for adult viral infection.